🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

B. Anderson

San Francisco General Hospital

ORCID: 0000-0001-5023-660X

Also affiliated with International Computer Science Institute, San Francisco VA Medical Center, Kaiser Permanente, University of California, San Francisco, Suffolk University, Johns Hopkins University Applied Physics Laboratory, University of California System, Multidisciplinary Association for Psychedelic Studies, University of California, Berkeley

PsychologyChemistryPhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines”.

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines

Neuropharmacology(2022)10.1016/j.neuropharm.2022.109214
N/A
0DataRank · unranked
49 citations

Lynnette A. Averill, Jack E. Henningfield, Stephen N. Xenakis, Ingrid Donato, Charles S. Grob +5 more

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics

Journal of Pain(2022)10.1016/j.jpain.2022.05.003
N/A
0DataRank · unranked
22 citations

B. Anderson, Nick Andrews, Robert R. Edwards, Charles S. Grob, Stephen Ross +3 more

Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms

Journal of Psychoactive Drugs(2022)10.1080/02791072.2021.1983673
N/A
0DataRank · unranked
1 citations

B. Anderson, Gabrielle Agin-Liebes, Joseph Guydish, Ciarán Martin Fitzpatrick

On Minimizing Risk and Harm in the Use of Psychedelics

Psychiatric Research and Clinical Practice(2025)10.1176/appi.prcp.20240128
N/A
0DataRank · unranked
18 citations

Marc Aixalà, B. Anderson, William Brennan, Rebecka Bremler, Joost J. Breeksema +26 more